NM-23 H1 immunohistochemistry is not useful as predictor of metastatic potential of colorectal cancer.

por Lindmark, G.
Publicado 1996

The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.

por Lindmark, G., Bergström, R., Påhlman, L., Glimelius, B.
Publicado 1995

The importance of rectal washout for the oncological outcome after Hartmann’s procedure for rectal cancer: analysis of population-based data from the Swedish Colorectal Cancer Regi...

por Jörgren, F., Johansson, R., Arnadottir, H., Lindmark, G.
Publicado 2017

Expression of tissue inhibitor of metalloproteinases TIMP-2 in human colorectal cancer--a predictor of tumour stage.

por Ring, P., Johansson, K., Höyhtyä, M., Rubin, K., Lindmark, G.
Publicado 1997

Microsatellite instability in sporadic colorectal cancer is not an independent prognostic factor

por Salahshor, S, Kressner, U, Fischer, H, Lindmark, G, Glimelius, B, Påhlman, L, Lindblom, A
Publicado 1999

Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT–PCR

por Ohlsson, L, Hammarström, M-L, Israelsson, A, Näslund, L, Öberg, Å, Lindmark, G, Hammarström, S
Publicado 2006

Lymph node tissue kallikrein-related peptidase 6 mRNA: a progression marker for colorectal cancer

por Ohlsson, L, Lindmark, G, Israelsson, A, Palmqvist, R, Öberg, Å, Hammarström, M-L, Hammarström, S
Publicado 2012

Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer.

por Kressner, U., Glimelius, B., Bergström, R., Påhlman, L., Larsson, A., Lindmark, G.
Publicado 1998

Stromal tenascin distribution as a prognostic marker in colorectal cancer.

por Kressner, U., Lindmark, G., Tomasini-Johansson, B., Bergström, R., Gerdin, B., Påhlman, L., Glimelius, B.
Publicado 1997